Tatar, E <br/><br/>
Use of kidney donors with hepatitis B, hepatitis C, or brain tumor: a single-center experience.  [electronic resource] 

 -  Transplantation proceedings   
 - 1601-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2623 
<br/><br/><label>Standard No.: </label>10.1016/j.transproceed.2012.04.028  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Alanine Transaminase--blood<br/>Antiviral Agents--therapeutic use<br/>Biomarkers--blood<br/>Brain Neoplasms--complications<br/>DNA, Viral--blood<br/>Donor Selection<br/>Hepatitis B--complications<br/>Hepatitis B Antibodies--blood<br/>Hepatitis B Surface Antigens--blood<br/>Hepatitis B Vaccines--therapeutic use<br/>Hepatitis B virus--genetics<br/>Hepatitis C--complications<br/>Hepatitis C Antibodies--blood<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Kidney Transplantation--adverse effects<br/>Middle Aged<br/>Postoperative Complications--etiology<br/>Retrospective Studies<br/>Time Factors<br/>Tissue Donors--supply & distribution<br/>Treatment Outcome<br/>Turkey